Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways.
about
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysisHeterogeneity of glycolysis in cancers and therapeutic opportunities.Metabolic shifts during aging and pathologyCardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxiaCrystal structure of the hypoxia-inducible form of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): a possible new target for cancer therapyMicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranosideActivation of glycogen synthase in myocardium induced by intermittent hypoxia is much lower in fasted than in fed rats.Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.Reduced cardiac fructose 2,6 bisphosphate increases hypertrophy and decreases glycolysis following aortic constrictionTwo ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle.Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection.AMP-activated protein kinase β-subunit requires internal motion for optimal carbohydrate bindingDeficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Insulin signalling in the heart.AMPK: Lessons from transgenic and knockout animalsProtective effects of AMP-activated protein kinase in the cardiovascular system.α-Lipoic acid as a triglyceride-lowering nutraceutical.Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids.5'AMP-activated protein kinase alpha deficiency enhances stress-induced apoptosis in BHK and PC12 cells.Targeting Metabolic Reprogramming by Influenza Infection for Therapeutic Intervention.Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality.Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo.Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor AntagonismCardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity.Effects of insulin and actin on phosphofructokinase activity and cellular distribution in skeletal muscle.Mouse strain differences in metabolic fluxes and function of ex vivo working hearts.5'-AMP-activated protein kinase is inactivated by adrenergic signalling in adult cardiac myocytes.Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia.Loss of Metabolic Flexibility in the Failing Heart.
P2860
Q24528111-D19CA041-48E9-4A82-88C0-F8DFA2DC1F52Q27693375-D2226CB6-3064-466A-8A50-E3A6EAD1967DQ28088313-5F93E7A9-4042-401B-8BD4-207E279D2945Q28278944-45FB5EFD-1183-4E97-BC8F-767D2C9DEFBAQ28284323-F7BB5A52-C768-42D1-9585-9C531DA84FA2Q29871002-1EF4E16E-A385-4696-9E90-33D8F6A4EF1BQ30406455-E1663BCF-5AE1-4136-AE34-56956E216419Q30441700-9F335E75-5344-46FB-845D-EB1A6C81DF87Q33489603-93510B46-A060-4900-B1B8-FCC481AA05F1Q34357440-4CDFA579-A6B4-4644-A827-737273FFB7D4Q34545425-0FD2B48C-1F4A-4319-9C23-B9286333FAAAQ34750255-790DD5C4-4493-41FE-B8C4-269D72903303Q35087457-3124A9E6-2461-450B-A277-546190DD8EE3Q35694226-827231DB-57D8-453D-8969-ABC430FDBD9EQ36246003-FDDE0925-DCD7-483C-A627-504EB2446DE1Q36844816-0FA5A77C-6B2F-4C50-A524-95ABB1BE1FDCQ37129268-87F7EB13-8B47-40A3-88ED-1C2860C598ECQ37153612-2AC72BBB-E960-451E-8B25-9847171538FBQ37793322-CBAD4294-E09B-42D2-8E11-6AC8256405B0Q38559352-E6BCD058-63EE-4F7C-AEFA-1C99EA5A4389Q39795284-B65B37D1-E08B-4EFB-BCED-7E1227FF5B4AQ40135196-2D3B5019-7CAA-49D8-B048-8AE885CBBB10Q40188145-B25D6D34-73CA-4DDE-B1F4-294DE9277356Q40493855-83F81981-E4BE-45F7-AD63-0C1CC18E98E7Q40616025-C5124697-242E-45F9-9790-E6B39EF90C8BQ41455445-C4443FA6-A4EE-4747-9CC0-08AD7ECB510BQ41912188-93D74665-9ED9-4896-A9D4-004F040875D0Q42466673-3BBEF48A-B441-488F-BF12-8B1B942579A4Q45034739-739C30E6-BFB0-4450-8CCD-8DEFB878CFD6Q46733241-13CE5829-24B5-4138-A430-64FA5AECE99CQ53225075-02AC5DCB-2A9B-4AC6-82FE-59A52474F692Q53608212-471A8CFD-7FC0-4634-BE99-604EA62D0EEEQ55341036-305ED67D-C183-4B81-9439-75398090DA7E
P2860
Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@ast
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@en
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@nl
type
label
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@ast
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@en
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@nl
prefLabel
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@ast
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@en
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@nl
P2093
P356
P1476
Insulin and ischemia stimulate ...... d opposing signaling pathways.
@en
P2093
Anne-Sophie Marsin
Christophe Beauloye
Luc Bertrand
Mark H Rider
Sandrine Horman
P304
P356
10.1006/JMCC.2002.2063
P577
2002-09-01T00:00:00Z